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A B S T R A C T
Purpose: To investigate the utility of single photon emission computed tomography (SPECT) without
subtraction and MRI co-registration in decision making for epilepsy surgery
Methods: Patients with refractory epilepsy and nonlocalizing or discordant non-invasive data (clinical,
long-term VEEG, and MRI) were subjected to interictal and ictal SPECT studies before planning invasive
or surgical strategy. Final localizationwas based upon the preoperative information and seizure freedom
after surgery. SPECT was considered to be useful for decision-making if it obviated the need for
intracranial monitoring or inﬂuenced its planning.
Results: 61 patients (mean age, 25.1  8.3 years) underwent SPECT studies between January 2004 and
December 2008. Twenty-two patients had mesial temporal lobe epilepsy (MTLE), 13 had neocortical
temporal lobe epilepsy (NTLE), and 26 had extratemporal lobe epilepsy (ETLE). As compared to ETLE, SPECT
provided more localizing information (77.3% vs 46.2%, p = 0.006) and inﬂuenced the ﬁnal decision-making
(45.4% vs 11.53%, p = 0.005) in a signiﬁcantly higher number of patients with MTLE. SPECT was particularly
useful in patients with lesional TLE and nonlocalizing ictal data and in thosewith dual pathologies. SPECT did
not provide any additional information in patients having either TLE or ETLE with normal MRI.
Conclusions: SPECT is useful in a selected group of patients and unlikely to provide additional
information in others. By restricting its use in patients who are likely to be beneﬁted, a cost-effective
utilization strategy can be employed in countries with limited resources. Due to the small number, these
ﬁndings need to be validated in a larger group of patients.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Single photon emission computed tomography (SPECT) is
routinely used for the localization of the epileptogenic focus in
patients undergoing presurgical evaluation for medically refracto-
ry epilepsy. Localization provided by the visual analysis of
interictal and ictal SPECT images has been reported to be
concordantwith othermodalities likemagnetic resonance imaging
(MRI) and Video-EEG (VEEG) in 90% of patients with temporal
lobe epilepsy and 60–70% of patients with extratemporal lobe
epilepsy.1–9 Accuracy of the information provided by the SPECT
studies can be further enhanced by the use of more objective* Corresponding author at: Department of Neurology, Sree Chitra Tirunal
Institute for Medical Sciences and Technology, Trivandrum 695 011, Kerala, India.
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doi:10.1016/j.seizure.2010.10.033analytical methods like subtraction ictal SPECT co-registered to
magnetic resonance imaging (SISCOM) and statistical parametric
mapping (SPM).10–14 Accordingly, SPECT is considered an essential
component of presurgical evaluation protocol for medically
refractory epilepsy and many centers, especially in the developed
countries, routinely undertake SPECT studies for all such
patients.15
However, it is known that SPECT usually provides concordant
information in patients whose ictal onset zone can otherwise be
well localizedwith the help ofMRI and VEEG data. In such patients,
obtaining additional concordant information with the help of
SPECT is generally unnecessary. In contrast, SPECTmight be helpful
in those patients where other tests especially scalp VEEG and MRI
are nonlocalizing and an unequivocal ictal onset zone cannot be
clearly delineated. Though these are the patients most likely to be
beneﬁted by SPECT studies, surprisingly very little information is
available regarding the exact utility of SPECT in this group of
patients. Previous studies have either evaluated the localizingvier Ltd. All rights reserved.
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postoperative seizure outcome.1–17 Very few studies have evalu-
ated the utility of SPECT in inﬂuencing the surgical decision-
making.18–20 These studies have also shown inconsistent results
mainly because of the heterogeneous study subjects and varied
studymethods. Moreover, no information is available regarding its
utility in inﬂuencing decision making in different epilepsy
subgroups.
As performing a SPECT study especially an ictal SPECT is a labor
intensive and costly proposition, its cost-effective utilization is
important particularly in developing countries where the optimal
use of limited resources is essential for the wider beneﬁt of the
community. Performing the SPECT studies for all the patients
undergoing presurgical evaluation is neither necessary nor
feasible. Gains of a SPECT study can be maximized in a cost-
effective manner by restricting its use in those patients where it is
likely to add to decision making and avoiding in patients where
source localization can be achieved with basic tests like VEEG and
MRI. Hence, predicting the utility of the SPECT study in a given
patient is important for more scientiﬁc and cost-effective
utilization.
With this background, we undertook this study with the
following objectives: (1) to study the utility of interictal and ictal
SPECT studies in inﬂuencing the surgical decision making for the
patients with medically refractory epilepsy; (2) to identify the
characteristics of the patients who are likely to be beneﬁted with
the use of SPECT studies so as to develop an approach towards its
cost-effective utilization.
2. Methods
2.1. Study setting
All the patients with medically refractory epilepsy attending
the R. Madhvan Nayar Center for Comprehensive Epilepsy Care,
Trivandrum, Kerala undergo a standard stepwise presurgical
evaluation.21 As the ﬁrst step, all such patients are subjected to
high resolution 1.5 T MRI, long-term VEEG monitoring and
neuropsychological evaluation. If these basic tests provide
unequivocal localizing and concordant information, enabling to
generate the hypothesis regarding the probable epileptogenic zone
and subsequent surgical decision-making, then further evaluation
is not performed. However, if the information obtained from these
basic tests is nonlocalizing or discordant, failing to provide a clear
hypothesis for further decision making, then such patients are
typically subjected to functional imaging [SPECT and/or positron
emission Tomography (PET)] followed by intracranial monitoring,
if required. Decisions for the SPECT studies are usually made at the
end of the VEEG monitoring or during the comprehensive patient
management conference, by a team comprising of epileptologists
and neuroradiologists when a consensus opinion decides that the
further evaluation is needed and is feasible. Decision to undertake
functional imaging and the nature of the imaging (PET or SPECT) is
typically individualized according to the baseline information and
also to some extent inﬂuenced by the ﬁnancial condition of the
patient.
2.2. Subjects
During the period from January 2004 to December 2008, a total
of 2702 patients underwent VEEG monitoring. Out of these, 61
patients with nonlocalizing or discordant baseline data underwent
interictal and ictal SPECT studies. Demographic and clinical details
of these patients were retrospectively retrieved from the database
maintained at the epilepsy center. The study was approved by the
institute review board.2.3. Long-term VEEG monitoring
All patients underwent long-term video-EEG monitoring
utilizing standard 10–20 system of electrode placement with
additional anterior temporal (T1, T2) electrodes. Sphenoidal
electrodes were inserted in patients with suspected temporal
lobe epilepsy who had nonlateralizing or discordant ictal electro-
clinical data. All the data were reviewed by the two epileptologists.
At least two habitual seizures were recorded for every patient. The
presence and distribution of interictal epileptiform discharges
(IEDs) during wakefulness and sleep was assessed by visual
analysis of a minimum of 5 min of data every hour during a 24-h
period, by two epileptologists (CR and KR).
2.4. MRI evaluation
All patients underwent a 1.5 TMRI utilizing a standard protocol
as described in detail previously.22 The neuroradiologist attached
to the epilepsy program (CK) interpreted the MRI and ﬁndings
were prospectively recorded.
2.5. SPECT study
All the SPECT studies were performed during the long-term
VEEG monitoring using 99mTc-ethyl cysteinate dimer (ECD) as the
radiotracer. Radiotracer was injected by trained nurses at the
earliest appearance of either the clinical or EEG changes. Timing of
the ictal injection was determined from the time of the ﬁrst EEG
change to the time when the plunger of syringe was fully
depressed. SPECT studies were performed using dual-headed
gamma camera system equipped with low energy high resolution
collimators (LEHR). The data were acquired in a 128  128 byte
matrix over 360 degrees with 120 views, 25 s per view, obtained at
3-degree intervals using a circular orbit. The energy setting was
140 keV with a 15–20% window. Transaxial images were
reconstructed using a Butterworth ﬁlter (power = 10, critical
frequency 0.45, full width half-maximum [FWHM] = 6 mm) re-
binned into a 128  128 matrix with a 2 zoom. Attenuation
correction (Chang order 0, coefﬁcient 0.11) was applied, and a
standard series of contiguous images was created in the transaxial,
coronal, sagittal, and transtemporal planes. The reconstructed
system resolution was approximately 7 mm FWHM and was
composed of cubic voxels with dimensions of 3.6 or 4.4 mm
(depending on the image size) and images were visualized on the
monitor. Ictal images were obtained within 1 h of radiotracer
injection while interictal images were obtained after 24 h of
seizure free period. Images were interpreted individually by a
physician trained in nuclear medicine and another neuroradiolo-
gist who were blinded to the clinical data. Any discrepancy was
solved by mutual consensus. Based upon the visual analysis of the
interictal and ictal images, SPECT studies were classiﬁed as
localizing (localized to one lobe or sublobar region), lateralizing
(involvement of more than one lobes), nonlateralizing (normal or
diffuse involvement), falsely localizing (localized to the lobe other
than the actual site of seizure origin) and falsely lateralizing.
2.6. Analysis of data and decision making
After obtaining the necessary investigations, details of all the
patients undergoing presurgical evaluation were discussed in the
multidisciplinary patient management conference. All such dis-
cussions and further decisions were entered into the database.
Reasons for undertaking SPECT study were also noted during the
proceedings of patientmanagement conference. For the purpose of
this study, we retrospectively ascertained the following data from
the charts: type of seizure and epilepsy syndrome, interictal and
Table 1
Utility of SPECT in different epilepsy subgroups.
SPECT results MTLE
(n=22)
NTLE (n=13) ETLE (n=26) P value
(MTLE vs NTLE)
P value
(MTLE vs ETLE)
P value
(NTLE vs ETLE)
Mean injection time (s) 25.713.1 25.28.6 21.311.7 0.73 0.11 0.23
Proportion of generalized
seizures, n (%)
03 (14) 03 (23) 08 (30.7) 0.25 0.27 1.0
Lateralization, n (%) 17 (77.2) 11 (84.6) 20 (76.9) 1.0 0.48 0.69
Localization, n (%) 17 (77.2) 07 (63.6) 12 (46.2) 0.65 0.006 0.09
False lateralization, n (%) 01 (4.5) 0 (0) 1 (3.8) 1.0 1.0 1.0
False localization, n (%) 02 (9.0) 0 (0) 5 (19.2) 0.91 0.11 0.84
Helpful in decision making n (%) 11 (50) 3 (23.1) 3 (11.53) 0.17 0.005 0.38
MTLE—Mesial temporal lobe epilepsy; NTLE—Neocortical temporal lobe epilepsy; ETLE—Extratemporal lobe epilepsy.
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seizure during the ictal injection (partial or secondarily general-
ized). Final lateralization and localization was decided by the
combination of clinical data, seizure semiology, interictal and ictal
EEG, MRI results, and in selected patients from the informationTable 2
Characteristics of patients where SPECT was considered to be helpful in further decisio
Sr no. Age Final localization IEDs Ictal localization M
1 18 MTLE Right temporal Temporal; Uncertain
lateralization
R
2 25 MTLE Left temporal Temporal; Uncertain
lateralization
L
3 23 MTLE Left temporal Probable left
temporal
B
(L
4 30 MTLE Right temporal; few
right posterior
temporal
Right hemispheric R
5 22 MTLE Left temporal Uncertain
lateralization
L
6 32 MTLE Bilateral temporal Uncertain
lateralization
R
7 18 MTLE Left temporal Uncertain
lateralization
L
d
8 30 MTLE Bilateral temporal Uncertain
lateralization
R
9 28 MTLE Bilateral temporal Uncertain
ateralization
R
10 20 MTLE Right temporal Uncertain
lateralization
R
11 32 MTLE Right temporal Right temporal R
L
ca
12 17 NTLE Bilateral temporal Uncertain
lateralization
L
g
13 29 NTLE Bilateral temporal Uncertain
lateralization
R
te
d
14 15 NTLE Left posterior
temporal
Left hemispheric S
p
te
d
15 18 ETLE Left posterior
head region
Left hemispheric N
16 25 ETLE Bilateral frontal Left hemispheric Le
17 35 ETLE Left parietal Uncertain Le
ri
h
MTLE: Mesial temporal lobe epilepsy, NTLE: Neocortical temporal lobe epilepsy, ETLE
lobectomy, MTS: Mesial temporal sclerosis.obtained by intracranial monitoring and seizure freedom after
surgery. According to the ﬁnal localization we divided the patients
into three groups: mesial temporal lobe epilepsy (MTLE),
neocortical temporal lobe epilepsy (NTLE) and extratemporal lobe
epilepsy. In patients with normal MRI, following features weren-making.
RI SPECT Decision Outcome
ight MTS Right
temporal
Right ATL Persistent
auras; Seizure free
eft MTS Left Temporal Left ATL Seizure free
ilateral MTS
eft> right)
Left temporal Left ATL Seizure free
ight MTS Right temporal Right ATL Seizure free
eft MTS Left temporal Left ATL No improvement
ight MTS Right temporal Right ATL Seizure free
eft amygdalar
ysplasia
Left temporal Lesionectomy Seizure free
ight MTS Right temporal Right ATL Seizure free
ight MTS Right temporal Right ATL Seizure free
ight MTS Right temporal Right ATL Seizure free
ight MTS;
eft occipital
lciﬁcation
Right temporal Right ATL Seizure free
eft basal temporal
anglioglioma
Left temporal Lesionectomy Seizure free
ight anterior
mporal
ysplasia
Right lateral
temporal
Right ATL Seizure free
uspected left
osterior
mporal
ysplasia
Left posterior
temporal
Selected for
intracranial
monitoring
Awaiting
ormal Left occipital Selected for
intracranial
monitoring and
occipital
lobectomy
Seizure free
ft parietal dysplasia Left parietal Lesionectomy Seizure free
ft parietal dysplasia,
ght periventricular
nodular
eterotopia
Left parietal Left parietal
lesionectomy
Seizure free
: Extratemporal lobe epilepsy, IEDs: Interictal discharges, ATL: Anterior temporal
[()TD$FIG]
Fig. 1. EEG andMRI data for a patient with right mesial temporal lobe epilepsy with hippocampal sclerosis (A) Interictal sleep record showing right anterior temporal spikes;
(B) Ictal EEG during one of the seizures showing 5 Hz theta activity over the left temporal region with myogenic artifacts over right side; (C) Coronal T2 weighted image
showing right hippocampal atrophy with increased signal intensity; (D) Ictal SPECT (Upper panel) showing right temporal hyperperfusion as compared to interictal SPECT
(Lower panel). Patient is seizure free for one year following right anterior temporal lobectomy.
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childhood, epigastric or psychic aura, predominantly automotor
seizures with relative lack of clustering and secondary generaliza-
tion, strictly anterior temporal interictal discharges and Type IA
ictal pattern.22 Features which were considered to be suggestive of
neocortical temporal lobe epilepsy were: atypical initial precipi-
tating injury like encephalitis, relatively early age of onset,
auditory or vertiginous aura, hypomotor seizures with early head
version and facial jerks, presence of seizure clustering, more
frequent secondary generalization, mid-temporal or posterior
temporal IEDs and Type II or Type III ictal pattern.22–24 We judged
the utility of the SPECT study by its ability to provide information
over and above provided by the initial basic tests and thus helping
in further decision-making. The further decision was either to
undertake surgical excision or undertake intracranial monitoring.
SPECT was considered to be useful if it obviated the need for
intracranial monitoring or it inﬂuenced the feasibility and type of
intracranial coverage in a given patient. All such discussions were
noted in the proceedings of patientmanagement conference. Team
consensus during these proceedings was used to determine the
utility of SPECT. In case of any uncertainty, all the data for the givenpatient were reviewed by the two epileptologists (CR and KR) to
determine whether SPECT helped in further decision making.
2.7. Statistical analysis
We summarized the quantitative data as mean  standard
deviation (SD). Three different epilepsy groups were compared with
regard to the ability of SPECT to provide the localizing and lateralizing
information, its concordance with the ﬁnal localization and its ability
to inﬂuence the ﬁnal decisionmaking using Fisher’s exact test. P value
of <0.05 was considered signiﬁcant.
3. Results
For the 61 patients (38 males, 23 females), who underwent
SPECT study, mean duration of epilepsy was 15.7  6.8 years and
mean age at evaluation was 25.1  8.3 years. Final diagnosis was
MTLE in 22 patients, NTLE in 13 patients and extratemporal lobe
epilepsy in 26 patients. Utility of the SPECT in providing localizing,
and lateralizing information as well as its ability to add to the ﬁnal
decision-making in these three groups is presented in Table 1.
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group was 25.2  8.6 s and for ETLE was 21.3  11.7 s. There was
no difference in the mean injection time and proportion of the
generalized seizures during ictal SPECT among the three groups
(Table 1). SPECT provided concordant lateralizing information in
80% of the patients in each group. However, as compared to the
patients with extratemporal lobe epilepsy, SPECT provided
signiﬁcantly more localizing information in patients with MTLE
(77.3% vs 46.2%, p = 0.006) and NTLE (63.6 vs 46.2, p = 0.09). SPECT
was considered to be helpful in further decision making in 17 (28%)
patients. Details of all the patients where SPECT helped in further
decision making is provided in Table 2. It provided information
over and above the one provided by the baseline tests and thus
inﬂuenced the ﬁnal decision making in a signiﬁcantly higher
number of patients with MTLE than extratemoral lobe epilepsy
(50.0% vs 11.53%, p = 0.005).
3.1. Mesial temporal lobe epilepsy
The patients with TLE could be divided into three broad groups
depending upon the baseline characteristics: patients with
unilateral mesial temporal lobe epilepsy associated with hippo-
campal sclerosis (MTLE-HS) and nonlocalizing ictal data (Group 1,
n = 13), those with MTLE and normal MRI (Group 2, n = 07), and
those with dual pathology (Group 3, n = 2). SPECT was particularly
useful for decisions making in group 1 as compared to group 2
(84.6% vs 0, p < 0.003). The 13 patients in the ﬁrst group had all the
data (clinical history, interictal EEG and MRI) concordant for
unilateral MTLE-HS except the ictal recordings (Table 2; Fig. 1).
Ictal semiology and ictal EEG in these patients were either
discordant or nonlateralizing. In ten patients, ictal SPECT provided
the localization which was concordant to the majority of data.
These patients were selected for anterior temporal lobectomy on
the basis of additional information provided by SPECT studies, thus
obviating the need for depth monitoring. Eight out of these 10
patients became seizure free following surgery; one had persistent
auras but no seizures while remaining one patient had no beneﬁt
with surgery. In remaining three patients, SPECT provided
nonlocalizing information. Two of the patients in MTLE group,
had unilateral hippocampal sclerosis with contralateral ictal
onsets on scalp EEG, so called ‘‘wasted hippocampus syndrome’’.25
SPECT showed ipsilateral localization in one and contralateral
localization in the other patient. The patient in whom it showed
contralateral localization, the radiotracer was injected after 45 s of
[()TD$FIG]Fig. 2. EEG andMRI data for a patient with right mesial temporal lobe epilepsy with hipp
(B) Ictal EEG after 10 s of onset during one of the seizures showing polymorphic theta
hippocampal atrophywith increased signal intensity; (D) Ictal SPECT (Injection time of 45
8-contact hippocampal depth electrodes showing seizure origin from contacts 3 and 4
following right anterior temporal lobectomy.ictal onset (Fig. 2). This patient underwent bilateral hippocampal
depthmonitoringwhich conﬁrmed the seizure origin from the side
of hippocampal sclerosis. Both the patients became seizure free
following anterior temporal lobectomy. In the second group with
normal MRI, SPECT showed concordant localization in all the
patients. However, it failed to provide any additional information
over and above that provided by the VEEG monitoring. Out of the
seven patients, two patients underwent surgery, three opted for
the medical management and two are awaiting surgery. One
patient became seizure free following surgery while other had no
beneﬁt. Two patients with dual pathology and temporal lobe
epilepsy had calciﬁed neurocystecircus granuloma in addition to
the hippocampal sclerosis, one at the ipsilateral left superior
temporal gyrus and other at the contralateral occipital lobe. SPECT
showed the localization in relation to hippocampal sclerosis in
both the patients. In the ﬁrst patient, it was considered as false
localization since all the other data indicated towards the superior
temporal gyrus as the site of seizure origin. The second patient
became seizure free following anterior temporal lobectomy (ATL).
3.2. Neocortical temporal lobe epilepsy
Out of the 13 patients with NTLE, six had normal or equivocal
MRI ﬁndings, ﬁve had single lesion and equivocal ictal EEG while
two had dual pathology. Three out of the ﬁve patients with single
lesions showed SPECT localization in relation to the lesion and
were selected for the surgery. SPECT was nonlocalizing in the
remaining two patients. Out of the six patients with normal MRI,
three showed SPECT localization to the lateral temporal lobe while
three showed both mesial and lateral temporal hyper perfusion on
ictal SPECT. In all these cases SPECT was not considered to provide
any additional information and thus inﬂuence the ﬁnal decision-
making. While three of these patients underwent further
intracranial monitoring and subsequent neocortical resection,
others are awaiting further evaluation or opted for the medical
management. SPECT did not provide information sufﬁcient for the
further decision making in two patients with dual pathologies, one
with right hemispheric atrophy, right MTS and right occipital
gliosis and other with left parietal and temporal dysplasias.
3.3. Extratemporal lobe epilepsy
Extratemporal lobe epilepsy patients could be divided into two
broad groups: patients with normal MRI (Group 1, n = 15), andocampal sclerosis (A) Interictal sleep record showing right anterior temporal spikes;
activity over the left temporal region; (C) Coronal T2 weighted MRI showing right
s) showing left temporal hyperperfusion; (D) Intracranial monitoringwith bilateral
of the right sided depth electrode (arrow); Patient is seizure free for three years
[()TD$FIG]
Fig. 3. EEG and MRI data for a patient with extratemporal epilepsy (A) Interictal sleep record showing spikes over the left posterior head region (T5, P3, O1); (B) Ictal EEG
showed only artifacts with no discernible ictal activity; (C) Axial FLAIR image showing left parietal dysplasia (arrow); (D) Axial T2weightedMRI showing right periventricular
heterotopia (arrow); (D) Ictal SPECT (Upper panel) showing left parietal hyperperfusion as compared to interictal SPECT (Lower panel).
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unequivocal ictal onset zone could not be determined (Group 2,
n = 11). SPECT was considered to be useful in only three patients:
one with normal MRI and occipital epilepsy where SPECT results
were useful in reducing the extent of intracranial coverage. Details
of other two patients alongwith all the other patients where SPECT
was considered to be useful in decision-making are presented in
Table 2 (Fig. 3). Importantly, in ﬁve (19.2%) of patients with ETLE,
SPECT provided false localization to the ipsilateral temporal lobe
suggesting a seizure propagation rather than origin (Fig. 4).
4. Discussion
Our results indicate that SPECT provides additional information
and is helpful in making decision about epilepsy surgery in a
selected group of patients. Overall, SPECT provided additional
information in about a quarter of our patients. SPECT is especially
useful in patients with MTLE and uncertain ictal localization and
those with widely spaced dual pathologies. Our results also show
that its utility in patients with normal MRI is rather limited.
In our patients, SPECT provided concordant lateralizing
information in 80% of the patients with all type of epilepsies
and localizing information in 80% of patients with temporal lobe
epilepsy and 45% of patients with extratemporal lobe epilepsy.
These ﬁnding are similar to numerous previous studies showing
high degree of concordance between SPECT and other investiga-tions.1–15 However, our results also demonstrate that actual utility
of SPECT in providing the additional information over and above
the one provided by the other baseline investigations is rather
limited. Very few studies have evaluated the actual utility of SPECT
in inﬂuencing the surgical decision-making. A recent study with
321 patients showed that focal ﬁndings on theMRI or EEGwere the
most important in inﬂuencing the surgical decision making while
SPECT did not contribute to the decision-making.18 Other
investigators have also questioned the utility of the SPECT in
temporal lobe epilepsy.19 Similarly, in another prospective study,
the localized results on SISCOM inﬂuenced the decision making in
only one third of the patients.20 Our results further extend these
ﬁndings by identifying the subgroup of the patients where SPECT
can be really useful in further decision-making, thus paving the
way for the more cost-effective utilization of this modality.
SPECT was found to bemost useful in patients with lesional TLE
and nonlocalizing electrophysiological data. MTLE associated with
hippocampal sclerosis is a heterogeneous entity, with variable
electro-clinical characteristics.26 Approximately one-third of
patients with lesional TLE may have nonlocalizing ictal rhythms.24
By providing additional concordant information, SPECT can
potentially obviate the need for intracranial monitoring in this
group of patients. One can argue that these patients may be
selected for temporal lobectomy even without the ictal recordings.
However, the present day epilepsy surgery calls for the concordant
information from multiple sources to maximize the chances of
[()TD$FIG]
Fig. 4. EEG andMRI data for a patient with left basi-frontal dysplasia (A) Interictal record showing left anterior temporal spikes; (B) Ictal EEG showing 7 Hz theta activity over
the left temporal region which appeared after 10 s of clinical onset; (C) T2W coronal, (D) Fluid attenuated inversion recovery (FLAIR) coronal, and (E) FLAIR axial MRI images
showing left basifrontal dysplasia (arrow) with normal hippocampi; (F) Ictal SPECT (Lower panel) showing predominantly left temporal hyperperfusion as compared to
interictal SPECT (Upper panel). Patient was advised to undergo intracranial monitoring but opted for the medical management.
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in this group of patients. SPECT may also be potentially useful in
patients with ‘‘wasted hippocampus syndrome’’, provided the
radiotracer is injected sufﬁciently early. However, this aspect
requires further study in a larger group of patients.We did not ﬁnd
SPECT to be useful for further decision-making in patients with
normal MRI and either MTLE or NTLE. Major issue in this group of
patients is to differentiate MTLE from NTLE and TLE from
‘‘temporal plus epilepsies’’ or pseudotemporal epilepsy.27 Due
to the extensive connections of the temporal lobe with other
limbic structures and with parieto-occipital regions, seizures
originating from these areas can rapidly propagate to the
temporal lobe and these patients may present as temporal lobe
epilepsy. As the perfusion patterns also follow the ictal patterns,
SPECT may provide a false localization to the temporal lobe in
these patients.5 Similarly, an ictal SPECT is more likely to depict
thewidespread hyperperfusion involving the limbic network,28,29
and is unlikely to differentiate the seizures arising form the
operculoinsular or basifrontal region from those originating at
mesial or lateral temporal regions, in a given patient. These
patients can either be selected noninvasivelywithout the need for
SPECT or can be subjected to intracranial monitoring depending
upon the original hypothesis.22 Similarly, we did not ﬁnd it to be
useful in patients with extratemporal lobe epilepsy and normal
MRI. SPECT can provide reliable lateralizing information in this
group of patients. However, localizing value in this subset of
patients is rather limited with high false positive results. All of
these patients showed false localization to ipsilateral temporal
lobe suggesting seizure propagation rather than the site of seizure
origin, suggesting that SPECT results should be evaluated in the
context of other data.Other potential group where SPECT can provide the useful
information is the patients with widely spaced dual pathologies. It
is not uncommon to ﬁnd incidental but potentially epileptogenic
calciﬁed lesions in countries endemic for neurocystecercosis.30,31
SPECT can obviate the need for intracranial monitoring in these
patients when other data is nonlocalizing. Similarly, it could also
be useful in patients with tuberous sclerosis with multiple tubers.
We acknowledge the following limitations of our study. There is
a potential selection bias, as SPECTwas undertaken only in patients
where the initial data was nonlocalizing and in whom further
evaluation was considered worthwhile. Many patients were
excluded from the further evaluation based upon the baseline
data. However, it will be difﬁcult to assume that SPECT is likely to
provide any extra information in these patients. Thus our patients
are fairly representative of the group where the SPECT is likely to
be considered useful. Similarly, it is difﬁcult to ascertain that
whether the use of the other analytical methods like SISCOM or
SPM would have altered the results. Although SISCOM and SPM
have shown to have more localizing value than the visual
analysis,10–14 their utility in inﬂuencing the decision making has
not been compared. Similar to our results, use of the SISCOM was
found to contribute to the decision-making in only one-third of the
patients.20 One more limitation may be the non-availability of the
ﬁnal localization in few patients which can be proven only by the
intracranial monitoring or seizure freedom following surgery.
However, our aim was to study the utility of SPECT in surgical
decision-making in a clinical setting and not to study its ﬁnal
localizing value. For this purpose, the consensus decision-making
at the multidisciplinary patient management conference is a
validated method used across all the major epilepsy surgery
centers.32 It needs to be emphasized that in spite of proven validity,
C. Rathore et al. / Seizure 20 (2011) 107–114114the results represent the decision-making process at our center
and might slightly differ across the centers. Similarly, ability to
detect signiﬁcant differences between different subgroups may be
limited due to the small number of patients in this study and
results needs to be validated in a larger group of patients.
Presurgical evaluation is a cost-intensive procedure where
multiple tests are undertaken to obtain the best possible
concordance so as to maximize the chances of seizure freedom.
Undertaking an additional test is likely to escalate the cost of the
overall evaluation by several folds. The radiotracers used in the
SPECT study have short half lives of 4–6 h and multiple ﬁllings are
often needed for the successful completion of an ictal SPECT. These
radiotracers are costly and not freely available for many centers in
India. Moreover, an ictal SPECT requires the constant presence of
an EEG technologist and a trained nurse to ensure the timely
injection of the radiotracer. All these factors escalate the cost of a
SPECT study and consequently of the overall presurgical evalua-
tion. At our center undertaking a successful ictal SPECT costs
approximately Indian Rupees 8000–10,000 (Euro, 150–200), which
is beyond the reach of many patients. This calls for the selective
utilization of the SPECT where it is likely to provide additional
information and avoiding it where the information is likely to be
redundant. Our results are helpful in developing a cost effective
strategy in countries with limited resources for the better
utilization of SPECT during presurgical evaluation.
5. Conclusions
We conclude that SPECT is potentially useful in few selected
patients where it can inﬂuence the further decisions making while
it is a redundant investigation in others. By restricting its use in
those patients where it has a high probability of inﬂuencing the
further decision making rather than using it for all the patients, a
cost effective strategy can be evolved especially in countries with
limited resources.
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